6550--VISN 22 IMMUNOASSAY REAGENTS FOR LIAISON XL analyzer

The Department of Veterans Affairs Veterans Health Administration (VA VISN 22) is seeking immunoassay reagents and related services for the LIAISON XL analyzer system across five VA healthcare facilities in California and Arizona. The procurement will cover 52 DiaSorin brand laboratory reagents, controls, calibrators, and supplies necessary for various diagnostic testing, including tests for Vitamin D, CMV, EBV, and SARS-CoV-2. The contract will be conducted under FAR Part 12 and 13 commercial item procedures, with interested parties required to submit capability statements by 9:00 AM PT on March 3, 2025, to Rebecca.Gaba@va.gov. Vendors must provide FDA-approved reagents compatible with existing DiaSorin Liaison XL instruments using "Flash" chemiluminescence technology. Qualification criteria include having ready-to-use reagents with barcodes, minimum 12-month expiration dates, and the ability to provide monthly shipping and instrument maintenance.

The pre-solicitation notice indicates no specific set-aside for small businesses, though Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB) are encouraged to respond with SBA certification proof. DiaSorin, a large business headquartered in Stillwater, MN, is the intended sole-source contractor, with Epredia noted as the only authorized service provider. The contract will be a one-year firm-fixed price agreement with a potential 6-month extension option. While specific award values are not disclosed, the pricing template suggests significant volume for certain items, such as 1,200 units of LIAISON 25 OH Vitamin D Total Assay and 355 units of LIAISON XL Disposable Tips. Service will primarily cover hours between 7:30 AM to 5:00 PM Monday-Friday, with potential for 24/7 coverage, and will be performed within the VISN 22 region, which includes healthcare systems in Long Beach, Loma Linda, San Diego, Southern Arizona, and Greater Los Angeles.